Head-To-Head Analysis: Editas Medicine (EDIT) vs. NewLink Genetics (NASDAQ:NLNK) – The Lincolnian Online
Stocks Gallery |
Head-To-Head Analysis: Editas Medicine (EDIT) vs. NewLink Genetics (NASDAQ:NLNK)
The Lincolnian Online It is developing a genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR) technology. CRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either CRISPR associated protein 9 … Financial Newsletter – Zacks |
